SCHEMBL21716265

SCHEMBL21716265

c1cc(-c2nc3ccccc3nc2-c2ccc3c(ccc4ccccc43)c2)cc(-n2c3ccccc3c3cc4c(-n5c6ccccc6c6cc7ccccc7cc65)cccc4cc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.39
TDP1 Q9NUW8 1/20 0.33
PDE10A Q9Y233 3/20 0.32
RAD51 Q06609 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
HTR6 P50406 2/20 0.31
TUBB4A P04350 1/20 0.30
TUBB P07437 1/20 0.30
TUBA3C P0DPH7 1/20 0.30
TUBA1B P68363 1/20 0.30
TUBA4A P68366 1/20 0.30
TUBB4B P68371 1/20 0.30
TUBB3 Q13509 1/20 0.30
TUBB2A Q13885 1/20 0.30
TUBB8 Q3ZCM7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716819 0.98 GSR (0.36) GSRTDP1PDE10ARAD51KDM4E
SCHEMBL21716903 0.93 GSR (0.33) GSRTDP1RAD51ALDH1A1
SCHEMBL21717020 0.93 GSR (0.34) GSRTDP1PDE10ARAD51KDM4E
SCHEMBL21716473 0.92 GSR (0.39) GSRTDP1RAD51KDM4EATM
SCHEMBL21716378 0.91 ATM (0.35) GSRTDP1KDM4EATML3MBTL1
SCHEMBL21716957 0.90 GSR (0.39) GSRPDE10ARAD51KDM4EATM
SCHEMBL21716831 0.90 L3MBTL1 (0.38) GSRTDP1RAD51KDM4EATM
SCHEMBL24079241 0.89 GSR (0.36) GSRTDP1L3MBTL1GAAHTR6
SCHEMBL21716687 0.89 GSR (0.36) GSRTDP1L3MBTL1GAAHTR6
SCHEMBL21717584 0.88 ATM (0.37) GSRTDP1KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 GSR 3951/4885TDP1 1382/4885PDE10A 3123/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 GSR 3951/4885TDP1 1382/4885PDE10A 3123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.